Direct and quantitative determination of Angiotensin Converting Enzyme (ACE) activity. The ACE kinetic assay allows clinical routine laboratories the measurement of the enzyme activity in serum with an easy to use procedure on most open clinical chemistry platforms. Validated and CE marked protocols are provided with a complete reagent package including calibrator and controls.
Reliable and sensitive quantification of Angiotensin Converting Enzyme (ACE) activity in Cerebrospinal fluid (CSF) is still a challenge. BÜHLMANN provides the first commercial CE marked and non-radioactive tool, allowing reliable ACE determination in CSF.
Flexible turbidimetric assay applicable on all major clinical analyzers. The high through-put assay offers a measuring range from 20-8000 µg/g and is standardized against the BÜHLMANN fCAL® ELISA.
The enzymatic GHB assay is a three reagent test which can be applied on clinical chemistry platforms. For modern mid/high throughput analyzers a simplified two-reagent protocol is possible. The assay allows an efficient way to screen for GHB in a real 24/7 service to your customer.
The vitamin B6 enzymatic assay allows for rapid and batch-wise detection of potential vitamin B6 deficiency or overdose. The 3-reagent protocol can be applied on some clinical analyzers.